XClose

UCL Cancer Institute

Home
Menu

Welcome to the UCL Cancer Institute 

The UCL Cancer Institute is the hub for cancer research at University College London, one of the World's leading universities. The Institute draws together over 300 talented scientists who are working together to translate research discoveries into developing better, more effective therapies for cancers and improve outcomes for cancer patients. If you are thinking about postgraduate study with us, applications to our flagship MSc Cancer programme are now open for the academic year 2017/18, or find our more about our postgraduate research

News and features


HRH The Duke of Kent visits UCL Cancer Institute

His Royal Highness The Duke of Kent visited laboratories at University College London (UCL) today to hear about a cutting-edge research project looking at ways to overcome treatment resistance in the most common form of childhood leukaemia. 

Published: Feb 1, 2017 5:03:05 PM

New non-invasive test to detect bladder cancer developed

A new test for bladder cancer could enable GPs to test a urine sample and spare patients the discomfort of a cystoscopy in hospital, according to research published today in Clinical Epigenetics

Published: Jan 31, 2017 2:52:42 PM

Landmark study provides insight into chemotherapy treatment for lung cancer patients

A research team, led by UCL, has published the results of a highly anticipated clinical trial comparing platinum and non-platinum chemotherapy in the Journal of Clinical Oncology. The aim of this trial was to see whether doctors could select the most effective chemotherapy treatment for advanced lung cancer patients. 

Published: Jan 13, 2017 12:07:27 PM

Light therapy set to transform prostate cancer treatment

A new non-surgical treatment for early, low-risk prostate cancer can effectively kill cancer cells while preserving healthy tissue, reports a new phase III clinical trial in 413 patients led by Professor Mark Emberton, Dean of UCL Medical Sciences and consultant urologist at UCLH. The trial was funded by STEBA Biotech which holds the commercial license for the treatment.

Published: Dec 20, 2016 10:16:16 AM

Cancer Research UK-UCL Centre

Cancer Research UK-UCL Centre

The Cancer Research UK-UCL Centre is a network and partnership between Cancer Research UK, UCL and UCL's associated Hospital Trusts. The Centre's mission is to facilitate collaboration to advance world-class translational cancer research.

Study with us

Study with us

Our education programmes reflect the depth and breadth of research expertise within the UCL Cancer Institute. Join our community of research scientists and academic clinicians through our postgraduate taught MSc Cancer or PhD studies.

Clinical Trials

Clinical Trials

The Cancer Research UK and UCL Cancer Trials Centre is one of the largest cancer trials centres in the UK. The CTC conducts multi-centre national and international phase III trials, feasibility studies and early phase I and II studies.

Our Research

Our Research

UCL is a world leader in interdisciplinary research. The UCL Cancer Institute is uniquely placed to leverage this multidisciplinary approach to advance discoveries in basic, translational and clinical cancer research.

Events

Support our work

UCL philanthropy

Help us to continue the research that will lead to the breakthroughs in cancer therapies that will benefit the lives of cancer patients.

Taking action for equality

Athena Swan silver logo

Connect with us

TwitterYoutubeMail